Vivera Pharmaceuticals Partners with EcoGroup USA in the Distribution of its BioZone Sanitizing Stations

Vivera Pharmaceuticals is excited to announce a distribution partnership with EcoGroup USA for Vivera's BioZone, an advanced access control device intended for sanitization in high occupancy settings. BioZone is designed to combine facial recognition, integrated biometrics, and a hospital grade FDA and EPA approved organic sanitization mist (OSM) to provide a completely integrated solution for high occupancy and high traffic settings. It can be customized to address the specific and diverse needs of different facilities.

Vivera Pharmaceuticals' CEO, Paul Edalat said, "Technology like BioZone is central to closing the gap between restoring safety and instilling confidence in workplaces and public venues again. An integrated solution, BioZone allows for maximum flexibility in how back to work or back to school protocols are set. BioZone is an additional piece to the overall puzzle, and Vivera is looking forward to working with EcoGroup USA on expanding the reach of COVID-19 solutions."

This statement from Mr. Edalat reiterates EcoGroup USA's mission in providing solutions for a safe and healthy work environment to all businesses. Dr. Harold Haines Ph.D., Chief Technology Officer of EcoGroup USA, added, "We welcome the addition of Vivera Pharmaceuticals into EcoGroup USA's growing list of American and International partners who contribute new and innovative products, services, and technologies, which strengthen and expand our existing solutions for preventing and controlling the spread of infectious disease agents, including COVID-19, in indoor environments. Vivera's BioZone is a unique, personal, whole-body sanitizing and thermal imaging system which perfectly complements our existing technology platforms by identifying potential carriers of COVID-19 and by providing whole body sanitization and personal identification."

Related Posts

Subscribe Our Newsletter